About Anastasiya Kazhan
This author has not yet filled in any details.So far Anastasiya Kazhan has created 26 blog entries.
GrowDMD Presented at the 2024 Annual Meeting of the Society for Neuropediatrics (GNP)
At the Annual Meeting of the German Society for Neuropediatrics (GNP) in October 2024 in Stuttgart, Prof. Dr. Thorsten Langer from the University Medical Center Freiburg presented key findings from the GrowDMD project.
GrowDMD Research Presented at WMS 2024 Prague
Alessia Marcassoli from the Fondazione IRCCS Istituto Neurologico Carlo Besta in Milan and Sebastian Friedrich from University Hospital Freiburg traveled to Prague to represent the GrowDMD project at the World Muscle Society 2024 congress. Together, they presented three research posters addressing the critical issue of healthcare transition for young people with Duchenne muscular dystrophy.
Meeting in Montreal October 2024
From October 2–4, 2024, researchers, clinicians, individuals living with Duchenne Muscular Dystrophy, and their families gathered in Montreal, Canada, for the international GrowDMD meeting.
GrowDMD wins DGSPJ Poster Award at Pediatric Congress 2024
We are honored to announce that the GrowDMD project was awarded the Poster Prize of the German Society for Social Pediatrics and Adolescent Medicine (DGSPJ) at the Congress for Pediatric and Adolescent Medicine 2024 in Mannheim.
GrowDMD Takes First Prize at Transition Hub Competition in Vancouver
The GrowDMD project won first prize in the poster competition at the Transition to Adulthood Pop-Up event in Vancouver in December 2023. Anne Fournier and Rocio Gutierrez represented the international research team at the Child Health Hub event, held at the Hyatt Regency on December 2-3, 2023. […]
GrowDMD Team at the 5th International Conference on Rare Diseases
The GrowDMD research team presented their international study at RARE2023, the 5th International Conference on Rare Diseases. Sebastian Friedrich from University Hospital Freiburg represented the collaborative team spanning Germany, Italy, and Canada at this premier gathering of rare disease researchers, clinicians, and patient advocates.